TrialRadiation oncology (London, England)2022

Stereotactic MRI-guided radiation therapy for localized prostate cancer (SMILE): a prospective, multicentric phase-II-trial.

J Ristau et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.